KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash from Operations (2016 - 2025)

Biogen (BIIB) has 17 years of Cash from Operations data on record, last reported at 511900000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations fell 32.72% year-over-year to 511900000.0; the TTM value through Dec 2025 reached 2204600000.0, down 23.33%, while the annual FY2025 figure was 2204600000.0, 23.33% down from the prior year.
  • Cash from Operations reached 511900000.0 in Q4 2025 per BIIB's latest filing, down from 1272500000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1272500000.0 in Q3 2025 and bottomed at 175000000.0 in Q4 2022.
  • Average Cash from Operations over 5 years is 582575000.0, with a median of 609100000.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: plummeted 120.88% in 2022, then soared 5987.2% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 838300000.0 in 2021, then tumbled by 120.88% to 175000000.0 in 2022, then surged by 107.14% to 12500000.0 in 2023, then skyrocketed by 5987.2% to 760900000.0 in 2024, then crashed by 32.72% to 511900000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 511900000.0 in Q4 2025, 1272500000.0 in Q3 2025, and 160900000.0 in Q2 2025.